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Purpose: Juvenile epithelial corneal dystrophy of Meesmann (MCD, OMIM 122100) is a dominantly inherited disorder
characterized by fragility of the anterior corneal epithelium and intraepithelial microcyst formation. Although the disease
is generally mild and affected individuals are often asymptomatic, some suffer from recurrent erosions leading to
lacrimation, photophobia, and deterioration in visual acuity. MCD is caused by mutations in keratin 3 (KRT3) or keratin
12 (KRT12) genes, which encode cornea-specific cytoskeletal proteins. Seventeen mutations in KRT12 and two in
KRT3 have been described so far. The purpose of this study was to investigate the genetic background of MCD in a Polish
family.
Methods: We report on a three-generation family with MCD. Epithelial lesions characteristic for MCD were visualized
with slit-lamp examination and confirmed by in vivo confocal microscopy. Using genomic DNA as a template, all coding
regions of KRT3 and KRT12 were amplified and sequenced. Presence of the mutation was verified with restriction
endonuclease digestion.
Results: In the proband, direct sequencing of the polymerase chain reaction (PCR) product from amplified coding regions
of KRT3 and KRT12 revealed a novel 1493A>T heterozygous missense mutation in exon 7 of KRT3, which predicts the
substitution of glutamic acid for valine at codon 498 (E498V). Using PCR-Restriction Fragment Length Polymorphism
(RFLP) analysis, the mutation was demonstrated to segregate with the disease (four affected members, three non-affected)
and to be absent in 100 controls from the Polish population, indicating that it is not a common polymorphism.
Conclusions: Location of the E498V mutation emphasizes the functional relevance of the highly conserved boundary
motifs at the COOH-terminus of the α-helical rod domain in keratin 3 (K3).
Keratins are intermediate filament proteins that form a
dense fibrous scaffold within the cytoplasm of epithelial cells.
Based on the amino acid sequence, they are classified into type
I or type II intermediate filaments, which are expressed in
pairs and form obligate heterodimers in a tissue-specific and
differentiation-specific manner. The predominant function of
these structurally resilient polymeric proteins is to impart
mechanical strength to the cells [1]. In addition, accumulating
evidence suggests that keratins also have regulatory functions
influencing  cell  size,  proliferation,  translation  control,
organelle  transport,  malignant  transformation,  and  stress
responses [2].
Mutations in keratin genes result in an abnormal fragility
of epithelial cells, leading to their detachment, blistering of
tissues in response to even mild physical trauma, and impaired
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keratinization  [1,3].  Keratin  mutations  were  detected  in
several  human  diseases  affecting  the  epidermis  and/or  its
appendages, e.g., epidermolysis bullosa simplex (a group of
heritable skin blistering disorders), keratoderma disorders,
and  hair  and  nail  defects.  They  were  also  found  in
extracutaneous  epithelia  such  as  mucosa  and  corneal
epithelium [1].
The only known disorder associated with mutation in
cornea-specific  keratin  3  (KRT3)  and  keratin  12  (KRT12)
representing type II and I intermediate filaments, respectively,
is Meesmann corneal dystrophy (MCD) [4]. As with many
other keratin disorders, MCD is inherited as an autosomal
dominant  trait  with  variable  expression.  The  majority  of
mutations were found in KRT12 and only two in KRT3 [4-6].
All of them are located in the central α-helical rod domain
responsible for protein heterodimerization and higher order
polymerization.  They  cluster  in  the  highly  conserved
boundary segments of the rod domain either within its NH2-
(1A subdomain) or COOH- (2B subdomain) terminus [7].
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1713MCD is characterized by fragility of the anterior corneal
epithelium,  which  may  lead  to  its  recurrent  erosions.
Morphologically,  the  epithelium  is  disorganized  and
thickened  with  widespread  cytoplasmic  vacuolation  and
numerous  small,  round,  keratin  aggregate-laden
intraepithelial microcysts [5,8]. They appear in childhood and
increase in number with age. Although the disease is generally
mild, some patients present with symptoms of lacrimation,
photophobia, and intermittent diminution of visual acuity [8].
Here, we present the results of a clinical and molecular
study of a previously unreported Polish family with MCD in
whom a novel missense mutation in exon 7 of KRT3 was found
to  segregate  with  disease.  The  E498V  mutation  affects  a
highly conserved amino acid [9] at the COOH-terminus of the
K3  rod-domain  and  represents  the  third  mutation  to  be
detected in this gene. Other mutations found in KRT3 and
KRT12 to date are also reviewed.
METHODS
A  three-generation  Polish  family  with  four  affected
individuals was studied. All subjects gave informed consent
in accordance with the tenets of the Declaration of Helsinki.
A complete ophthalmological check-up including slit-lamp
examination and confocal microscopy in vivo by Rostock
Cornea Module (RCM) for HRT II (Heidelberg Engineering,
Dossenheim, Germany), a preferred laser scanning confocal
microscope  for  corneal  epithelium  evaluation  [10],  were
performed.
Genomic DNA was extracted from blood obtained from
all available family members (n=7). Control DNA samples
came  from  a  repository  of  anonymous  samples  (n=100,
female:male  ratio  1:1)  representative  of  the  background
population  of  Central  Poland,  which  has  been  described
previously [11]. Ophthalmologic status of these individuals
was not known.
DNA mutation screening was performed by amplifying
the entire coding region of KRT3 and KRT12 with primers
located in the noncoding sequences and designed based on the
reference sequences of the respective genes, NM_057088 and
NM_000223.  Polymerase  chain  reaction  (PCR)  was
performed at 94 °C for 2 min followed by 35 cycles at 94 °C
for 45 s, 57–63 °C for 90 s, 72 °C for 60 s, and 72 °C for 10
min. Primer sequences and annealing temperatures for each
primer set are given in Table 1. PCR products were examined
on 1% agarose gels and then sequenced using an ABI PRISM
377 DNA sequencer (Applied Biosystems, Foster City, CA)
and BigDye Termiantion cycle sequencing kit v. 3.1 (Applied
Biosystems).
The mutation in exon 7 was verified by polymerase chain
reaction-restriction  fragment  length  polymorphism  (PCR-
RFLP)  analysis  using  HphI  (MBI  Fermentas,  Vilnius,
Lithuania). The PCR reaction was performed with the same
primers as used for sequencing (Table 1), and the digestion
was performed according to the manufacturer’s instructions.
The digestion products were separated by electrophoresis in
2% agarose gels and visualized by ethidium bromide staining.
In the presence of the E498V mutation, the digestion resulted
in the bands of 304 bp and 260 bp whereas in the wild type
homozygotes, only a 304 bp band was observed. The PCR-
RFLP analysis was used to screen family members and 100
control  DNA  samples.  All  family  members  in  whom  the
E498V mutation was found by PCR-RFLP were also analyzed
by direct sequencing.
RESULTS
In the proband (III-1, 24 years old), the diagnosis of MCD was
made on the basis of the typical clinical appearance of the
TABLE 1. PRIMERS FOR POLYMERASE CHAIN REACTION AMPLIFICATION AND SEQUENCING OF KRT3 AND KRT12, THEIR ANNEALING TEMPERATURE (TA), AND EXPECTED AMPLICON SIZE.
Gene/exon Forward primer sequence (5’→ 3’) Reverse primer sequence (5’→ 3’) Ta (°C) Product size
(bp)
KRT3
exon 1 TgCACAggTCTTCATTTCCCATCC TCCTCAACCCTggATATCTTCCCA 61 887
exon 2 AgTgTTgCCTgATgTTgCTTCCTg ACCATgCTTggAgAAggAAggTgA 61 439
exon 3 ATggAgggAgggAAgAgATgAACT ATTgCTCCAAAggCCTGAACTTgg 61 275
exon 4 gCTCTTTCTTgCTgCAgTTgTggT gCACCAgCCTCAAATCTggAAACA 60 238
exon 5 AgTgAACAAgCTCCCTCTgTgTTg TgAAACCTCCAgTggATCCCgTAA 60 235
exon 6 AAggTTTggTgggTgATgTTggAg ATTTgTggAgATACTgCCCTgTgg 61 345
exon 7 AATCCATTgCATgTCAggAAgggC TATCTGGCCCTTGGCCTATGACTT 60 354
exon 8 TgTTggTgATgTgCTTTgTgACgg AAgCCAATCACTTCCCTCTCCTCT 60 228
exon 9 ACAATAACATAgCAgCTggCCTgg AATACTCAgAggCCCggAgTgAAA 61 756
KRT12
exon 1a AgTgAACTTTTCAACTgCgA TgCCCgAgAgAATACCTAgA 61.5 450
exon 1b AggACTgggTgCTggTTAT CTgCAAgTACAgCTAAATTggA 62 447
exon 2 TAgggCTTCAATCTTgTgTgTgTCCC TTTATATCAATgAAggCAggACAgTAggAC 61.2 200
exon 3 CCCTCAACTgCTTTgCACTTggTT CTCCATACTTgTCCTgACTCCAgA 58.4 289
exon 4 CAgggCCCACgAAAgTCACAAT gTTCgCAggCCTTTCTgTgAATgT 58.3 272
exon 5 ACATTCACAgAAAggCCTgCgAAC TggAAgTCCAAAggATgCTACgTC 58.4 235
exon 6 gCTCgTgCgCAAACAgACgT CCCAggCATATCTTTACTAgA 60 490
exon 7 AgCCACCTgAACCACCTACTCTAA AgCTATgAggTTACAggCATgAgC 63 469
exon 8 gCCTACATTAAACAACCAgTgTTgg CAAgCAATCATCTTgCCTCTCAgC 61 684
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1714corneal microcysts, which were detected in both eyes during
routine eye examination (Figure 1 and Figure 2). They were
also found in three other family members I-2 (71 years old),
II-2 (49 years old), and III-2 (23 years old; Figure 3B). Patients
I-2, II-2, and III-1 were hyperopic from early childhood. None
of the affected family members complained about typical
symptoms of MCD.
The pedigree of the examined family was consistent with
an  autosomal  dominant  mode  of  inheritance  (Figure  3B).
Figure  1.  Slit-lamp  photography  of  proband  (III-1).  This  image
demonstrates the microcystic appearance of the corneal epithelium.
Figure 2. Confocal microscopy image of proband’s cornea. This
image shows the presence of hyperreflective material within the
intraepithelial cysts.
Since most mutations in MCD patients were found in exons 1
and 6 of KRT12 and the remaining two in exon 7 of KRT3,
these coding regions were initially sequenced in both the
forward and the backward directions in the proband. The
analysis  revealed  the  presence  of  a  novel  heterozygous
1493A>T transversion in exon 7 of KRT3 (Figure 3A). The
mutation predicts a glutamate to valine amino acid change at
codon 498 (E498V) within the region of highly conserved 2B
Figure 3. Identification of the heterozygous point mutation E498V
in exon 7 of KRT3 in the Polish MCD family. A: DNA sequencing.
Electropherograms from bidirectional sequencing of KRT3 exon 7 in
the  proband  showed  a  1493  A>T  (GAG>GTG)  heterozygous
mutation, predicting the amino aid change E498V. B: Pedigree of the
studied family. The arrow indicates the proband (III-1). C: PCR-
RFLP analysis. The KRT3 E498V mutation creates a recognition site
for HphI. The presence of this restriction site is seen to cosegregate
with MCD in this family. Upon digestion, the full sized 304 bp
product is cut into bands of 260 bp and 44 bp (the latter not visible
on the figure). DNA molecular weight markers are shown on the left
(lane 1). The heterozygous E498V mutation (lanes 3–6) was detected
in  all  affected  family  members  (I-2,  II-2,  III-1,  and  III-2).  The
homozygous normal allele, represented by the 304 bp band (lane 2,
7, and 8), was found in unaffected family members (II-1, II-3, and
III-3).
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1715rod  domain  segment  in  K3.  Sequencing  of  the  remaining
coding regions of KRT3 in the proband did not show any
alterations.
The E498V mutation creates a recognition site for the
HphI endonuclease. The PCR-RFLP analysis showed that the
E498V mutation cosegregated with the MCD phenotype in
the studied family members (Figure 3B,C). Using this method,
DNA  samples  from  100  subjects  from  the  background
population  of  central  Poland  were  also  screened,  and  no
carriers were found.
Sequencing  of  KRT12  exon  1  of  from  the  proband
revealed the presence of a common coding homozygous non-
synonymous single nucleotide polymorphism (rs11650915).
Additionally,  a  previously  unreported  heterozygous
substitution of A>C in the 3′ region of KRT12 (position NT:
2741849,  chromosome  17:36271079,  according  to
Genewindow)  was  detected.  The  latter  variant  did  not
segregate with the disease. It was found in affected members
(III-1 and III-2) as well as unaffected family members (II-3
and III-3).
DISCUSSION
The E498V mutation in KRT3 found in the Polish family with
MCD  affects  a  strongly  conserved  residue  within  the  2B
subdomain  of  the  intermediate  filament  chain  [9].
Conservation  of  an  amino  acid  residue  indicates  its
significance  for  protein  function  and  low  tolerance  to
replacement  [9,12].  The  E498V  mutation  predicts  a
particularly unfavorable substitution of a negatively charged,
polar  glutamate  to  an  aliphatic  and  hydrophobic  valine.
Glutamate is often present in the protein active or binding site.
It pairs with positively charged amino acids to create hydrogen
bonds, which are important for protein stability. Conversely,
valine is preferably present in protein hydrophobic cores. It
contains two substituents at its C-beta carbon, which restrict
the conformational changes that the main chain can adopt.
One of the most pronounced effects of this property is the
difficulty of valine to adopt an α-helical conformation [12].
Thus,  the  replacement  of  glutamate  to  valine  is  likely  to
influence both the physicochemical and structural properties
of the α-helical rod domain in K3, leading to the disruption of
the cytoskeletal keratin network.
All mutations in KRT3 and KRT12 reported to date affect
one or the other terminus of the central α–helical rod domain
and all but one (a 27 bp insertion [13]) are missense mutations
(Table  2,  Figure  4).  Of  note  is  also  the  lack  of  reported
mutations in the 1A subdomain of K3. Whether this is only a
chance finding resulting from the scarcity of genotyped MCD
cases  or  their  incompatibility  with  normal  development,
which seems less plausible, remains to be elucidated.
An interesting and yet unresolved issue in MCD is the
occurrence of asymptomatic cases despite the presence of
proven  KRT  mutations  and  morphological  findings.  An
example of such MCD presentation is the family reported in
this study. Interestingly, our case and the review of data on
the mutations and phenotypes reported so far in MCD (Table
2) and other diseases caused by keratin mutations may suggest
a  framework  for  understanding  genotype/phenotype
correlation in MCD.
Amino acids located in the boundary sequence motifs of
the keratin rod domain are highly conserved and particularly
important in intermediate filaments assembly as they mediate
end-to-end  interactions  between  keratin  heterodimers  and
filament elongation. These regions were found to represent
mutational hot spots in MCD as well as in other keratin types
[3]. mutations, which affect the boundary sequence motifs,
typically  exert  a  dominant-negative  effect  being  highly
disruptive to filament assembly and usually associate with the
severe disease phenotypes. In contrast, mutations in other
parts of keratin genes are compatible with filament assembly,
and  the  disease  phenotype  is  generally  milder  [5].
Interestingly, all three mutations, which so far have been
reported in asymptomatic patients (KRT12; V143L, KRT12;
I426V, and KRT3; E498V) or patients with relatively mild
symptoms (KRT12; I426S), are located innermost relative to
other mutations and possibly in less critical regions of the
boundary motifs of their respective subdomains (Figure 4).
The only exception is the KRT12 400ins9 mutation, which is
not directly comparable to other mutations since it leads to an
insertion  of  nine  novel  amino  acids  and  is  likely  to  be
damaging  to  filament  assembly  despite  a  relatively  long
distance from the terminus of the 2B subdomain (Figure 4).
These data suggest that putative missense mutations localized
internally in KRT12 (V143 and I426) or KRT3 (E498) are also
likely  to  be  asymptomatic  and  thus  provide  a  general
framework for genotype/phenotype correlation in MCD.
Figure 4. Schematic drawing of K3 and K12 structure with assigned
positions of the published mutations. Keratins are composed of three
main parts, the central α-helical rod domain, which is divided into
four subdomains (1A, 1B, 2A, and 2B), and the two non-helical
variable domains (V1 and V2) at each end [3]. All three mutations
within KRT3 localize exclusively in the boundary motif of the 2B
subdomain. Among the mutations in KRT12, 11 were found in the
1A subdomain and six in the 2B subdomain (see also Table 2).
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